Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer

Kenichi Sakurai, Sadanori Matsuo, Katsuhisa Enomoto, Mayumi Tani, Akira Kitajima, Sadao Amano

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

We evaluated the significance of indoleamine 2, 3-dioxygenase (IDO) in recurrent breast cancer during chemotherapy. IDO activity can be measured by tryptophan (Trp)/kynurenine (Kyn) ratio. Trp and Kyn were measured by high performance liquid chromatography (HPLC). The correlations among age and Trp/Kyn ratio or immunosuppressive acidic protein (IAP) value in pre-chemotherapies or post-chemotherapies were studied. In under 35-year-old patients, there were no correlations between pre-chemotherapy and post-chemotherapy in IAP values and Trp/Kyn ratio. But in over 36-year-old patients, both Trp/Kyn ratio and IAP value in post-chemotherapy were higher than in pre-chemotherapy. These results suggest that the immunological damages for the patients during chemotherapy may depend on the age of patients.

Original languageEnglish
Pages (from-to)1991-1993
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume36
Issue number12
Publication statusPublished - Nov 2009

Keywords

  • Breast cancer
  • Immunosuppressive acidic protein (IAP)
  • Indoleamine 2,3-dioxygenase (IDO)

Fingerprint

Dive into the research topics of 'Indoleamine 2,3-dioxygenase activity during chemotherapy in patients with breast cancer'. Together they form a unique fingerprint.

Cite this